Investor · San Carlos, CA

Peter Moldt

Open Peter in the network graph →

Filings

20

SEC Form D

Connections

187

co-filers

Capital

$383.1M

across filings

Active

Dec 2012

to Oct 2023

Most-connected co-filers (187)

Peter Thompson · New York, NY6 shared Asish Xavier · San Francisco, CA5 shared John P. Mckearn · St. Louis, MO4 shared Julie A. Smith · South San Francisco, CA3 shared Perry A. Karsen · South San Francisco, CA3 shared R. S. Williams · Thousand Oaks, CA3 shared Edgar Engleman · Palo Alto, CA3 shared Mahendra Shah · Redwood City, CA3 shared Judith Li · Danvers, MA2 shared Robert W. Karr · St. Louis, MO2 shared Christopher Bebbington · San Carlos, CA2 shared Pamela W. Manning · SAINT LOUIS, MO2 shared Leon Chen · San Francisco, CA2 shared Laura M. Brass · Cambridge, MA2 shared Nenad Tomasevic · San Carlos, CA2 shared David Allen · London, United Kingdom2 shared Ron Gershoni · Oakland, CA2 shared Jill Carroll · Gaithersburg, MD2 shared Grant Yonehiro · Redwood City, CA2 shared David S. Wachter · New York, NY1 shared Carole Neuchterlein · Cambridge, MA1 shared Richard T. Miller · Boston, MA1 shared Timothy C. Nichols · Dallas, TX1 shared Philip N. Dickie · Grand Cayman, Cayman Islands1 shared

Recent filings (20)

Avalyn Pharma Inc.Oct 2023 · 18 co-filers$189.2M Avalyn Pharma Inc.Oct 2023 · 18 co-filers$189.2M Swift Health Systems Inc.Sep 2021 · 18 co-filers$112.0M Bolt Biotherapeutics, Inc.Jun 2021 · 34 co-filers$15.0M Bolt Biotherapeutics, Inc.Jun 2021 · 34 co-filers$15.0M ESCAPE Bio, Inc.Sep 2020 · 19 co-filers$73.0M ESCAPE Bio, Inc.Sep 2020 · 19 co-filers$73.0M Aligos Therapeutics, Inc.Jan 2020 · 33 co-filers$125.0M Aligos Therapeutics, Inc.Jan 2020 · 33 co-filers$125.0M E-SCAPE BIO, INC.Jul 2019 · 9 co-filers$35.0M Outpost Medicine, LLCOct 2018 · 13 co-filers$56.0M Outpost Medicine, LLCOct 2018 · 13 co-filers$56.0M E-scape Bio, Inc.Oct 2018 · 16 co-filers$63.0M E-scape Bio, Inc.Oct 2018 · 16 co-filers$63.0M ViewPoint Therapeutics, Inc.Mar 2018 · 12 co-filers$35.0M ViewPoint Therapeutics, Inc.Mar 2018 · 12 co-filers$35.0M Bolt Biotherapeutics, Inc.Feb 2018 · 13 co-filers$6.0M E-scape Bio, Inc.Jun 2017 · 14 co-filers$63.0M E-scape Bio, Inc.Jun 2017 · 14 co-filers$63.0M Bolt Biotherapeutics, Inc.Sep 2016 · 9 co-filers$16.0M Bolt Biotherapeutics, Inc.Sep 2016 · 9 co-filers$16.0M Tioma Therapeutics, Inc.Aug 2016 · 15 co-filers$86.3M Tioma Therapeutics, Inc.Aug 2016 · 15 co-filers$86.3M Corvus Pharmaceuticals, Inc.Sep 2015 · 10 co-filers$75.0M Corvus Pharmaceuticals, Inc.Sep 2015 · 10 co-filers$75.0M

Derived from public SEC Form D (Reg D) filings; entities resolved probabilistically. See Peter in the interactive graph →